| Identification | Back Directory | [Name]
Protopanaxatriol | [CAS]
1453-93-6 | [Synonyms]
20(R)-APPT
20(R)-Protopanaxtriol
(20R)-Protopanaxatriol
20(R)-Protopanaxtriol(PPT)
Protopanaxatriol USP/EP/BP
Protopanaxatriol (20(R)-APPT
(20R)-Dammar-24-ene-3β,6α,12β,20-tetrol
(20R)-5α-Dammar-24-ene-3β,6α,12β,20-tetrol
(3β,6α,12β,20R)-Dammar-24-ene-3,6,12,20-tetrol
Dammar-24-ene-3,6,12,20-tetrol, (3β,6α,12β,20R)-
17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol | [Molecular Formula]
C30H52O4 | [MDL Number]
MFCD01861517 | [MOL File]
1453-93-6.mol | [Molecular Weight]
476.73 |
| Chemical Properties | Back Directory | [Melting point ]
261-263 °C | [Boiling point ]
590.0±50.0 °C(Predicted) | [density ]
1.079±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO : ≥ 32 mg/mL (67.12 mM); | [form ]
powder | [pka]
14.73±0.70(Predicted) | [color ]
White | [InChIKey]
SHCBCKBYTHZQGZ-DLHMIPLTSA-N |
| Hazard Information | Back Directory | [Uses]
20(R)-Protopanaxatriol is a natural aglycone of ginsenosides Re, Rf, Rg1, Rg2 and Rh. | [target]
COX | PPAR | [References]
[1] Bai L, et al. Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes. Front Pharmacol. 2018 May 1;9:423. DOI:10.3389/fphar.2018.00423 |
|
|